Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from Duality Biotherapeutics, Inc. ( (HK:9606) ).
Duality Biotherapeutics, Inc., a company incorporated in the Cayman Islands, has announced the full exercise of the Over-allotment Option, resulting in the issuance of 2,599,800 shares at HK$94.60 per share. This move represents approximately 15% of the total Offer Shares available under the Global Offering. The newly issued shares will facilitate the return of borrowed shares under a Stock Borrowing Agreement, used to cover over-allocations in the International Offering. The listing and trading of these shares on the Hong Kong Stock Exchange are set to commence on May 9, 2025. This development is expected to slightly adjust the company’s shareholding structure, increasing the public shareholders’ stake to 73.67%.
More about Duality Biotherapeutics, Inc.
Average Trading Volume: 1,719,989
For a thorough assessment of 9606 stock, go to TipRanks’ Stock Analysis page.